Chris was most recently CEO of The Integra Group, a contract medical research organization he founded in 2002, until its recent successful sale to the world’s largest organization in the medical device sector. At Integra, Chris was integrally involved in over 30 PMA approvals. Prior to that he was with Medtronic, where he built and ran Cardiac Rhythm Management’s clinical biostatistics group. Chris has three U.S. patents filed or pending. Chris has an MS in Biostatistics from the University of Minnesota.